feed,title,long_url,short_url
SeekingAlpha,"DocuSign surges as analysts praise results, calling them a 'step in the right direction'",https://seekingalpha.com/news/3881589,
SeekingAlpha,Bausch expects Xifaxan patent to hinder generic entry in US until 2029 despite approval,https://seekingalpha.com/news/3881587,
SeekingAlpha,"Zumiez stock plunges on slumping sales, light guidance",https://seekingalpha.com/news/3881588,
SeekingAlpha,Wall Street Breakfast: The Energy Edition,https://seekingalpha.com/article/4539936,
